BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30117442)

  • 1. Terbinafine-induced liver injury.
    Kaushal M; Tolani P; Kumar N; Sharma S
    Natl Med J India; 2017; 30(6):321-323. PubMed ID: 30117442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
    Agca E; Akcay A; Simsek H
    Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
    Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
    J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbinafine-induced hepatotoxicity.
    Mejías Manzano MLÁ; Giráldez Gallego Á; Ontanilla Clavijo G; Sousa Martín JM
    Gastroenterol Hepatol; 2019; 42(6):394-395. PubMed ID: 31167724
    [No Abstract]   [Full Text] [Related]  

  • 5. Terbinafine: Safety profile and monitoring in treatment of dermatophyte infections.
    Sun CW; Hsu S
    Dermatol Ther; 2019 Nov; 32(6):e13111. PubMed ID: 31595639
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis attributed to the use of terbinafine].
    Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terbinafine-associated hepatic injury.
    van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
    J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Progressive Cholestatic Drug-Induced Liver Injury Due to Terbinafine.
    Ley D; Musto J; Said A
    WMJ; 2023 May; 122(2):138-142. PubMed ID: 37141482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terbinafine used safely in autoimmune hepatitis for treatment of tinea corporis.
    Ferguson JE; Prouty M
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34035031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of laboratory abnormalities in patients prescribed terbinafine for onychomycosis.
    Wang Y; Geizhals S; Lipner SR
    J Am Acad Dermatol; 2021 Feb; 84(2):497-499. PubMed ID: 32387655
    [No Abstract]   [Full Text] [Related]  

  • 11. Concurrent terbinafine-induced acute generalised exanthematous pustulosis and hepatitis.
    Carnio LR; Johnson Shaw ME; Schnur J; Casadesus D
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terbinafine-associated hepatotoxicity.
    Ajit C; Suvannasankha A; Zaeri N; Munoz SJ
    Am J Med Sci; 2003 May; 325(5):292-5. PubMed ID: 12792250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis associated with terbinafine therapy: three case reports and a review of the literature.
    Gupta AK; del Rosso JQ; Lynde CW; Brown GH; Shear NH
    Clin Exp Dermatol; 1998 Mar; 23(2):64-7. PubMed ID: 9692307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terbinafine hepatotoxicity. A case report and review of literature.
    Zapata Garrido AJ; Romo AC; Padilla FB
    Ann Hepatol; 2003; 2(1):47-51. PubMed ID: 15094707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terbinafine-induced hepatic failure requiring liver transplantation.
    Perveze Z; Johnson MW; Rubin RA; Sellers M; Zayas C; Jones JL; Cross R; Thomas K; Butler B; Shrestha R
    Liver Transpl; 2007 Jan; 13(1):162-4. PubMed ID: 17192859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis associated with terbinafine treatment.
    Lowe G; Green C; Jennings P
    BMJ; 1993 Jan; 306(6872):248. PubMed ID: 8443524
    [No Abstract]   [Full Text] [Related]  

  • 17. Terbinafine exacerbates psoriasis: case report with a literature review.
    Szepietowski JC
    Acta Dermatovenerol Croat; 2003; 11(1):17-21. PubMed ID: 12718791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute hepatitis associated with terbinafine].
    Vivas S; Rodríguez M; Palacio MA; Cadenas F; Lomo J; Rodrigo L
    Gastroenterol Hepatol; 1997 Nov; 20(9):456-8. PubMed ID: 9445740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a Critically Appraised Topic.
    Kramer ON; Albrecht J
    Br J Dermatol; 2017 Nov; 177(5):1279-1284. PubMed ID: 28762471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbinafine-induced hepatitis and pancytopenia.
    Conjeevaram G; Vongthavaravat V; Sumner R; Koff RS
    Dig Dis Sci; 2001 Aug; 46(8):1714-6. PubMed ID: 11508672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.